Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

CFNL, PWRM, STLY, CRL - Cardinal Bank, Power3, Stanley Furniture, Charles River Laboratories




  Power3 Medical Products, Inc. (OTC:PWRM)

PWRM has filed several patent applications that are currently pending for its NuroPro technology. PWRM also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, PWRM has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China. PWRM has also published 6 articles on NuroPro in peer-reviewed scientific journals. PWRM intends to publish these latest findings as well.

PWRM, a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. PWRM’s products include BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer; and NuroPro, a serum test for the detection of neurodegenerative diseases, such as amyotrophic lateral sclerosis, Alzheimer’s disease, and Parkinson’s disease.

To learn more about PWRM visit:


Cardinal Bank (NASDAQ:CFNL) recently reported that Hilary J. Blackburn has assumed the new role of Vice President for Product Development and e-Commerce.

Hilary J. Blackburn was most recently in Director positions in Product Management and Information Technology at Capital One Bank. She has also held management positions in e-Commerce, Product Management, and Audit with other local financial institutions, including Chevy Chase Bank and Crestar, where she earned recognition for leadership, teamwork and service.

Hilary J. Blackburn has served in leadership roles with the Institute of Internal Auditors, Central Virginia Chapter, and the Banking Information Technology Secretariat, and has also conducted classes for the American Institute of Banking. Blackburn is a graduate of Radford University, and holds additional industry certifications. She was a member of the CheckFree Client Advisory Committee and the Forrester Interactive Marketing Council.


Stanley Furniture Company, Inc. (Nasdaq:STLY) recently reported that it has set the terms for its previously announced rights offering.

Under the terms of the rights offering, STLY will distribute, at no charge, to the holders of its common stock as of 5:00 p.m., New York time, on November 15, 2010, one transferable subscription right for each share of Stanley Furniture common stock then owned.

Each subscription right will entitle the holder to purchase .322226 shares of common stock at a purchase price of $3.00 per share. Assuming the rights offering is fully subscribed, STLY currently expects the gross proceeds of the offering to be approximately $10 million.


Charles River Laboratories International, Inc. (NYSE:CRL) recently reported its results for the third quarter of 2010.

For the quarter, net sales were $276.1 million, a decline of 7.2% from $297.5 million in the third quarter of 2009. Foreign currency translation reduced the reported sales by 1.6%. Sales declined in both the Preclinical Services (PCS) and Research Models and Services (RMS) segments.

On a GAAP basis, the net loss attributable to common shareholders for the third quarter of 2010 was $24.9 million, or $0.40 per diluted share, compared to net income of $37.3 million, or $0.57 per diluted share, for the third quarter of 2009. This quarter’s GAAP results include the impact of the previously reported $30.0 million fee related to the termination of the acquisition agreement with WuXi PharmaTech (Cayman) Inc.

On a non-GAAP basis, net income was $28.4 million for the third quarter of 2010, compared to $42.6 million for the same period in 2009, a decrease of 33.4%. Third-quarter diluted earnings per share on a non-GAAP basis were $0.45, a decrease of 30.8% compared to $0.65 per share in the third quarter of 2009. Both the GAAP and non-GAAP results were impacted by lower sales volume and higher costs related to CRL’s enterprise resource planning (ERP) initiative, partially offset by prior cost-savings actions.



Signup for FREE Daily Stock Alerts From


Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).